BRG
IBB icon

Bay Rivers Group’s iShares Biotechnology ETF IBB Stock Holding History

Bay Rivers Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$385K Sell
2,026
-96
-5% -$16.5K 0.13% 90
2026
Q1 		$358K Hold
2,122
– – 0.15% 79
2025
Q4 		$358K Sell
2,122
-19
-0.9% -$3.09K 0.14% 75
2025
Q3 		$309K Sell
2,141
-37
-2% -$5.05K 0.13% 77
2025
Q2 		$276K Sell
2,178
-180
-8% -$22.1K 0.13% 78
2025
Q1 		$302K Sell
2,358
-7
-0.3% -$949 0.16% 75
2024
Q4 		$313K Sell
2,365
-84
-3% -$11.8K 0.15% 70
2024
Q3 		$357K Sell
2,449
-50
-2% -$7.24K 0.18% 64
2024
Q2 		$343K Hold
2,499
– – 0.18% 58
2024
Q1 		$343K Sell
2,499
-54
-2% -$7.38K 0.19% 62
2023
Q4 		$347K Sell
2,553
-206
-7% -$25.1K 0.22% 56
2023
Q3 		$337K Sell
2,759
-248
-8% -$31.5K 0.26% 53
2023
Q2 		$382K Hold
3,007
– – 0.29% 49
2023
Q1 		$388K Sell
3,007
-23
-0.8% -$3.01K 0.34% 46
2022
Q4 		$398K Buy
3,030
+4
+0.1% +$517 0.4% 45
2022
Q3 		$354K Sell
3,026
-155
-5% -$19.2K 0.35% 49
2022
Q2 		$374K Sell
3,181
-15,892
-83% -$1.89M 0.33% 51
2022
Q1 		$2.48M Buy
19,073
+71
+0.4% +$9.25K 1.79% 24
2021
Q4 		$2.9M Buy
19,002
+339
+2% +$52.5K 1.77% 22
2021
Q3 		$3.02M Sell
18,663
-8
-0% -$1.35K 2.05% 19
2021
Q2 		$3.06M Buy
18,671
+481
+3% +$74.1K 2.17% 18
2021
Q1 		$2.74M Buy
18,190
+416
+2% +$66.1K 2.13% 19
2020
Q4 		$2.69M Sell
17,774
-223
-1% -$31.9K 2.26% 16
2020
Q3 		$2.44M Sell
17,997
-4,514
-20% -$612K 2.29% 13
2020
Q2 		$3.08M Buy
22,511
+122
+0.5% +$15.6K 3.18% 9
2020
Q1 		$2.41M Buy
22,389
+274
+1% +$31.5K 3.42% 9
2019
Q4 		$2.67M Buy
+22,115
New +$2.47M 2.58% 14

Other funds holding IBB

Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.73B AUM 20.99% 1-Year Est. Return
GIC
Generali Investments CEE Prague, Czech Republic $2.11B AUM 25.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AP
Appleton Partners Boston, Massachusetts $1.63B AUM 38.57% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return

Bay Rivers Group's IBB Position: Q2 2026 in Review

Bay Rivers Group reduced its iShares Biotechnology ETF (IBB) stake by 4.5% in Q2 2026, selling an estimated $16.5K and leaving 2,026 shares worth $385K. The position accounts for 0.13% of the portfolio, ranked #90.

Bay Rivers Group first reported a position in IBB in Q4 2019 and has held it in 27 quarters since. The position peaked at $3.08M in Q2 2020. 416 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Bay Rivers Group held 2,026 shares of iShares Biotechnology ETF worth $385K as of Q2 2026.
  • Bay Rivers Group sold 96 iShares Biotechnology ETF shares in Q2 2026, an estimated $16.5K.
  • iShares Biotechnology ETF made up 0.13% of Bay Rivers Group's portfolio in Q2 2026, its #90 holding.
  • Bay Rivers Group first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 27 quarters since.
  • Bay Rivers Group's iShares Biotechnology ETF position peaked at $3.08M in Q2 2020.
  • 416 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Bay Rivers Group's 13F filing for Q2 2026, filed 9 Jul 2026.